MOXIYST-B

MRP

MRP 225/-UNIT

Description

• Moxifloxacin HCI IP eq. to Moxifloxacin 0.5% w/v + Bromfenac Sodium eq. to Bromfenac 0.09% w/v + Benzalkonium Chloride Solution IP 0.01% V/V (As preservative) In a sterile Aqueous base 

Doses

• As directed by the Physician

Indication

• Helps treat bacterial eye infections
• Reduces eye redness and irritation
• Provides relief from eye pain and discomfort
• Helps control eye inflammation (swelling)